Schrödinger, Inc. (SDGR)
SDGRNASDAQ-GSBiotechnology: Pharmaceutical Preparations
$31.94
-1.45 (-4.34%) today
Regular session, Nov 10, 12:43 PM ET
- Market cap
- $2.40bn
- P/E
- –
- EPS, last 4 quarters
- $-0.7900
- Dividend yield
- –
- Day range
- $31.61 to $33.77
- 52-week range
- $10.95 to $33.78
- Average volume
- 2.26m
- Previous close
- $33.39
Analysts
5 coveringBuy3 buy, 2 hold, 0 sell
Targets a year out average $32.40, +1.4% from here
Earnings
next estimate $-0.0900Next report
Dec 2025
+438.5%
Mar 2026
-44.6%
Jun 2026
+113.3%
Sep 2026
+24.2%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $87.23m | $58.59m | $58.89m | $64.49m |
| Gross profit | $57.29m | $29.55m | $32.43m | $38.25m |
| Operating income | -$17.16m | -$48.79m | -$41.55m | -$26.13m |
| Net income | $32.51m | -$60.03m | $5.97m | -$37.71m |
Last four quarters: revenue $269.20m, margin -22.0%, free cash flow -$116.77m
News
8 latest- Schrödinger Consensus Price Target Increased by 24.57% to $31.77Fintel · 14 hours ago
- Schrödinger (SDGR) Q3 2026 Earnings Call TranscriptThe Motley Fool · 5 days ago
- What Schrodinger (SDGR) Said on Its Q3 Earnings CallMarketBeat · 6 days ago
- Schrödinger, Inc. Reports Third Quarter 2026 Financial ResultsFintel · 6 days ago
- Schrodinger, Inc. (SDGR) Reports Q3 Loss, Beats Revenue EstimatesZacks · 6 days ago
- SOPHiA GENETICS SA (SOPH) Reports Q3 Loss, Beats Revenue EstimatesZacks · Nov 3, 2026
- iRhythm Holdings, Inc. (IRTC) Earnings Expected to Grow: Should You Buy?Zacks · Oct 29, 2026
- Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to DeclineZacks · Oct 28, 2026
The company
Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger's software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- schrodinger.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.